Christopher M. Reynolds
Christopher M. Reynolds publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Multiple Myeloma Research and Treatments.
- World rank
- #3,205,906 of 7,710,434 ranked researchers
- Rank in United States
- #910,711 of 1,627,098
- Works
- 26
- Citations
- 1.5k
- Citations per work
- 56.6
What does Christopher M. Reynolds research?
Christopher M. Reynolds's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1765.8%
- Medicine1765.8%
- Everything else621.9%
- Life Sciences312.3%
- 1Oncology23% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Hematology12% of their works
- 4Molecular Biology12% of their works
- 5Pathology and Forensic Medicine11% of their works
- 6Genetics6% of their works
Research topics
Which keywords describe Christopher M. Reynolds's research?
The keywords of their largest research topics: Rituximab, Targeted Therapy, ALK Inhibitors, Classification, EGFR Mutations, Lymphoma, Cetuximab and Diagnosis Criteria.
- Mutational Signatures
- PROTACs
- Bone Marrow Niche
- Genomic Aberrations
- KRAS Mutations
- Diagnosis Criteria
- Lymphoma
- Classification
- Targeted Therapy
- Rituximab
- ALK Inhibitors
- EGFR Mutations
- Cetuximab
- International Myeloma Working Group
- Chronic Lymphocytic Leukemia
- BET Bromodomains
- Hematopoietic Stem Cells
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab102 topics
- Targeted Therapy82 topics
- ALK Inhibitors61 topic
- Classification61 topic
- EGFR Mutations61 topic
- Lymphoma61 topic
- Cetuximab51 topic
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- KRAS Mutations51 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
- BET Bromodomains31 topic
- Bone Marrow Niche31 topic
- Hematopoietic Stem Cells31 topic
- PROTACs31 topic
- Cancer Genomics21 topic
- Mutational Signatures21 topic
Where does Christopher M. Reynolds work?
Christopher M. Reynolds's main affiliation in the publication record is Michigan Cancer Research Consortium, United States.
How many publications and citations does Christopher M. Reynolds have?
OpenAlex counts 26 works and 1,471 citations for Christopher M. Reynolds, an h-index of 10, ranking #3,205,906 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher M. Reynolds. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.